Zoetis INC

Zoetis Inc. announced a quarterly dividend of $0.53 per share for the third quarter of 2026, payable on September 1, 2026.

Zoetis reported first quarter 2026 results with revenue of $2.3 billion, a 3% increase, and revised full-year guidance amidst a challenging operating environment.

Zoetis Inc. announced solid financial results for the fourth quarter and full year 2025, alongside optimistic guidance for 2026, driven by portfolio strength and innovation.

Zoetis Inc. announced its Board of Directors declared a $0.53 per share dividend for the second quarter of 2026, payable on June 2, 2026.

Zoetis Inc. completed a $2.0 billion private offering of 0.25% Convertible Senior Notes due 2029, with net proceeds primarily allocated to fund capped call transactions and repurchase approximately $1.8 billion of common stock.

Zoetis Inc. announced its Board of Directors declared a first-quarter 2026 dividend of $0.53 per share, representing a 6% increase from the previous year.

Zoetis Inc. reported a 3% increase in total revenue for Q1 2026, driven by international growth, while the U.S. segment experienced a decline due to competitive pressures.

Zoetis Inc. reports a 1% increase in total revenue to $2.4 billion and a 6% rise in net income attributable to Zoetis Inc. to $721 million for the third quarter ended September 30, 2025, driven by price growth and companion animal product sales.

Zoetis Inc. reports robust Q2 2025 financial results with significant revenue and net income growth, driven by strong companion animal product sales despite livestock segment challenges.

Zoetis Inc. announces a 1% increase in revenue for the first quarter of 2025, with growth primarily driven by the companion animal sector, while navigating foreign exchange headwinds and the impact of a recent divestiture.

Zoetis Inc. saw a significant increase in revenue and net income in the third quarter of 2024, primarily driven by its companion animal product segment.

Zoetis Inc. announced its second quarter 2024 financial results, with revenue increasing by 8% compared to the same period last year, driven by strong operational performance.

Zoetis Inc., a global animal health leader, reported a 2% increase in total revenue and an 8% rise in net income for fiscal year 2025, driven by companion animal product growth and strategic investments.

Zoetis Inc. announces its 2024 financial results, highlighting revenue growth driven by its companion animal segment and strategic investments in research and development.

Zoetis Inc.'s 2023 annual report highlights a 6% revenue increase and strong performance across both U.S. and international markets, with significant contributions from key companion animal products.

Keith Sarbaugh, Executive Vice President of Zoetis Inc., received 260 shares of common stock on July 10, 2026.

Kristin C Peck, Chief Executive Officer and a Director of Zoetis Inc., received 616 shares of common stock on July 10, 2026.

Abhay U Nayak, Executive Vice President of Zoetis Inc., received 215 shares of common stock on July 10, 2026.

Kevin Esch, Executive Vice President of Zoetis Inc., received 308 shares of common stock on July 10, 2026.

Rimma Driscoll, Executive Vice President of Zoetis Inc., received 238 shares of common stock on July 10, 2026.

Julie Fuller, Executive Vice President of Zoetis Inc., received 315 shares of common stock on July 10, 2026.

Zoetis Inc. has announced its 2026 Annual Meeting of Shareholders will be held virtually on May 20, 2026, with key items including director elections and advisory votes on executive compensation.

Zoetis Inc. has filed a definitive proxy statement with the SEC, outlining matters for shareholder consideration.

Zoetis Inc. has released its proxy statement detailing the agenda for the 2025 Annual Meeting of Shareholders, including the election of directors, an advisory vote on executive compensation, and a shareholder proposal.

Zoetis is urging shareholders to re-elect director Louise M. Parent, responding to ISS's recommendation against her due to concerns about shareholder engagement on special meeting rights.

Zoetis is reaffirming its commitment to a 25% threshold for special meeting rights, citing strong shareholder support and alignment with key investor proxy voting guidelines.

Zoetis Inc. will hold its Annual Shareholder Meeting on May 22, 2024, to vote on key proposals including the election of directors, executive compensation, and ratification of the company's accounting firm.

Vanguard Capital Management has reported a 7.17% beneficial ownership stake in Zoetis Inc. as of March 31, 2026.

The Vanguard Group amended its Schedule 13G for Zoetis Inc., reporting 0% beneficial ownership due to an internal organizational realignment.

The Vanguard Group reported an increased beneficial ownership of 10.84% in Zoetis Inc., holding 47,778,909 shares as of December 31, 2025.